BioNTech drops indications, stops making cell therapy at Maryland site
BioNTech said it's stopping work on an experimental cell therapy in certain indications, and is winding down cell therapy manufacturing at its Gaithersburg, MD site. “We have made the difficult decision to discontinue cell therapy ...
BioNTech said it's stopping work on an experimental cell therapy in certain indications, and is winding down cell therapy manufacturing at its Gaithersburg, MD site.
“We have made the difficult decision to discontinue cell therapy ...
